AIM2 DISCOVERY CENTER
Live / Allowed — Publication / registration review complete (as of 09 Sept 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 23 Apr 2026 filing date already counts against anyone who files later.
Record
- Serial number
- 99782654
- Mark type
- Word mark
- Filed
- 23 Apr 2026
- Published for opposition
- 29 Sept 2026
- Attorney of record
- Andrea Christensen
Goods and services
- Class 042 — Scientific and technological services: Pharmaceutical research and development; Medical and scientific research in the field of cardiometabolic disease using artificial intelligence
Owner
- Pfizer Inc., New York, NY, US
Prosecution history
- 02 Sept 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 02 Sept 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 02 Sept 2026 — EXAMINER'S AMENDMENT ENTERED
- 02 Sept 2026 — EXAMINERS AMENDMENT E-MAILED
- 02 Sept 2026 — EXAMINERS AMENDMENT -WRITTEN
- 01 Sept 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 01 Sept 2026 — NON-FINAL ACTION E-MAILED
- 01 Sept 2026 — NON-FINAL ACTION WRITTEN
- 28 Aug 2026 — ASSIGNED TO EXAMINER
- 26 Aug 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 23 Apr 2026 — APPLICATION FILING RECEIPT MAILED
- 23 Apr 2026 — NEW APPLICATION ENTERED